Full Text (PDF)
Short Communication

COVID 19, Diabetes, Homoeopathy

Tridibesh Tripathy

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Journal of Social Welfare and Management 16(3):p 157-158, September - December 2024. | DOI: https://doi.org/10.21088/jswm.0975.0231.16324.7

How Cite This Article:

Tridibesh Tripathy, COVID 19, Diabetes, Homoeopathy. India and UK. J Soc Welfare Manag. 2024;16(3):157–158

Timeline

Received : August 26, 2024         Accepted : October 08, 2024          Published : December 30, 2024

Abstract

The current article touches upon the link between diabetes drugs & homoeopathy. Following that, it delves into the issue of COVID 19 that has induced the diabetic risk. Subsequently, it explores what homoeopathy can offer to deal with the high diabetic risk induced by COVID 19. As viral issues like Mpox continues to bother human kind, the article emphasizes the role of homoeopathy to be applied on a large scale for the benefit of masses. The Essential Medicine properties of homoeopathy will only be a boon in this role.


References

  • 1.   Helt RIG etal. Text Book of Diabetes, 5th Edition. John Wiley & Sons. Inc.2017.
  • 2.   Murphy R, Lotus Materia Medica, 3rd edition, B. Jain publishers (P) Ltd, 2017, ISBN-978-81-319-0859-4.
  • 3.   Bailey C J. Metformin: historical overview. Diabetologia 2017:60:1566-1576.
  • 4.   Matsuo T etal. Effect of an Intestinal Disaccharidase inhibitor (AO-128) on obesity & diabetes. Am.J.clin. nutr. 1992:55:314s-317s.
  • 5.   Rieg T, Vallon V. development of SGLT1 & SGLT2 inhibitors. Diabetologia 2018:61:2079-2086.
  • 6.   Aly ZA, Cao B, the enduring effect of the COVID 19 pandemic on diabetes, The Lancet Diabetes & Endocrinology, v12,i08, page508-510, August 2024.
  • 7.   Keerthi B Y etal. New onset diabetes mellitus in post COVID 19 patients, Journal of Family Medicine Primary care 2022:11:5961-8.
  • 8.   Jayadevan R, long-term study finds COVID-19 increases diabetes risk, The Hindu, Sunday, July 28, 2024, page12.
  • 9.   Popularity of Homoeopathy in India, bjainpharma. com/blog/popularity-of-homoeopathy-in-India, 2023.
  • 10.   Prasad Raekha, Special Report on Homoeopathy, v370, 17th November, 2007. www.thelancet.com
  • 11.   GOI, Ministry of AYUSH, NLEAM, 8 February, 2022
  • 12.   NLEM, GOI, PIB, 13th September 2022, https://pib. gov.in
  • 13.   Tripathy T et.al, Homoeopathy in COVID-19, A treatment protocol for second and third wave, Sch Int J Tradit Complement Med 4(6):86-90.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

Tridibesh Tripathy, COVID 19, Diabetes, Homoeopathy. India and UK. J Soc Welfare Manag. 2024;16(3):157–158


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
August 26, 2024 October 08, 2024 December 30, 2024

DOI: https://doi.org/10.21088/jswm.0975.0231.16324.7

Keywords

COVID 19HomoeopathyDiabetes

Article Level Metrics

Last Updated

Tuesday 22 September 2026, 06:57:15 (IST)


2760

Accesses

7
293
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received August 26, 2024
Accepted October 08, 2024
Published December 30, 2024

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share